Skip to main content

Genericart Medicine vs Patanjali franchise: cost, royalty and terms compared

Both are healthcare & pharmacy franchises taking applicants in India, and both publish an investment figure. The table shows what each brand publishes, with what we found beyond that labelled: a * means a third-party report or our own estimate, not a brand-published term. We checked Genericart Medicine's terms in September 2026 and Patanjali's in October 2026.

Genericart Medicine and Patanjali compared
TermGenericart MedicinePatanjali
FranchiseChuno Score81 (provisional) · 64% data verified69 (provisional) · 51% data verified
StatusTaking franchiseesTaking franchisees
Investment₹8 L - ₹40 L₹2.5 L - ₹1 Cr
Franchise feeNot published₹18K
Ongoing takeNo royaltyNot published
Payback (claimed)24–60 months*Not published
Agreement term5 yearsNot published
Space150 sq ft100–2,000 sq ft
Outlets379 on its locator (claims 2,000)5,258 on its locator (claims 5,606)
Franchisor revenue₹56.81 Cr (FY25)Not found
Franchisor profit₹4.14 Cr (FY25)Not found
ModelFOFOFOFO
Terms checkedSept 2026Oct 2026

Read the full terms, sources and red-flag checks: Genericart Medicine, Patanjali. Want a different pair? Compare any brands side by side.

Frequently asked questions

How much does Genericart Medicine cost compared with Patanjali?

Genericart Medicine: ₹8 L - ₹40 L. Patanjali: ₹2.5 L - ₹1 Cr. These are the figures each brand publishes for its own format, not like-for-like totals: check what each one includes on its listing page before you compare them.

Do Genericart Medicine and Patanjali charge a royalty?

Genericart Medicine: No royalty. Patanjali: Not published. A figure marked with * is reported by a third party or is our labelled estimate, not a brand-published term.

Which has more outlets, Genericart Medicine or Patanjali?

Genericart Medicine: 379 on its locator (claims 2,000). Patanjali: 5,258 on its locator (claims 5,606). Counts are not always like-for-like: a number we recounted on the brand's own store locator is shown separately from the brand's own claim.

How were Genericart Medicine and Patanjali compared?

Both brands' terms were checked by FranchiseChuno (Genericart Medicine in September 2026, Patanjali in October 2026) against what each brand publishes. Anything a brand does not publish is shown as "Not published", never filled in. Payment never affects a score or a rank.